Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids

Samuel Flashner, Cecilia Martin, Norihiro Matsuura, Masataka Shimonosono, Yasuto Tomita, Masaki Morimoto, Ogoegbunam Okolo, Victoria X. Yu, Anuraag S. Parikh, Andres J.P. Klein-Szanto, Kelley Yan, Joel T. Gabre, Chao Lu, Fatemeh Momen-Heravi, Anil K. Rustgi, Hiroshi Nakagawa

Producción científicarevisión exhaustiva

4 Citas (Scopus)

Resumen

Esophageal squamous cell carcinoma (ESCC) is prevalent worldwide, accounting for 90% of all esophageal cancer cases each year, and is the deadliest of all human squamous cell carcinomas. Despite recent progress in defining the molecular changes accompanying ESCC initiation and development, patient prognosis remains poor. The functional annotation of these molecular changes is the necessary next step and requires models that both capture the molecular features of ESCC and can be readily and inexpensively manipulated for functional annotation. Mice treated with the tobacco smoke mimetic 4-nitroquinoline 1-oxide (4NQO) predictably form ESCC and esophageal preneoplasia. Of note, 4NQO lesions also arise in the oral cavity, most commonly in the tongue, as well as the forestomach, which all share the stratified squamous epithelium. However, these mice cannot be simply manipulated for functional hypothesis testing, as generating isogenic mouse models is time-and resource-intensive. Herein, we overcome this limitation by generating single cell-derived three-dimensional (3D) organoids from mice treated with 4NQO to characterize murine ESCC or preneoplastic cells ex vivo. These organoids capture the salient features of ESCC and esophageal preneoplasia, can be cheaply and quickly leveraged to form isogenic models, and can be utilized for syngeneic transplantation experiments. We demonstrate how to generate 3D organoids from normal, preneoplastic, and SCC murine esophageal tissue and maintain and cryopreserve these organoids. The applications of these versatile organoids are broad and include the utilization of genetically engineered mice and further characterization by flow cytometry or immunohistochemistry, the generation of isogeneic organoid lines using CRISPR technologies, and drug screening or syngeneic transplantation. We believe that the widespread adoption of the techniques demonstrated in this protocol will accelerate progress in this field to combat the severe burden of ESCC.

Idioma originalEnglish
Número de artículoe64676
PublicaciónJournal of Visualized Experiments
Volumen2022
N.º190
DOI
EstadoPublished - 2022

Financiación

FinanciadoresNúmero del financiador
National Institutes of Health2L30DK126621-02, KL2TR001874, R01CA255298-01S1, L30CA264714, R01DE031873, R01DK114436, R01AA026297, DE031112-01, R01DK132251, P30DK132710
American Association for Cancer Research
National Cancer InstituteR01CA266978, P01CA098101, P30CA013696
National Institute of Diabetes and Digestive and Kidney DiseasesDP2DK128801
Fanconi Anemia Research Fund20-60-51-MOME

    ASJC Scopus Subject Areas

    • General Neuroscience
    • General Chemical Engineering
    • General Biochemistry,Genetics and Molecular Biology
    • General Immunology and Microbiology

    Huella

    Profundice en los temas de investigación de 'Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids'. En conjunto forman una huella única.

    Citar esto

    Flashner, S., Martin, C., Matsuura, N., Shimonosono, M., Tomita, Y., Morimoto, M., Okolo, O., Yu, V. X., Parikh, A. S., Klein-Szanto, A. J. P., Yan, K., Gabre, J. T., Lu, C., Momen-Heravi, F., Rustgi, A. K., & Nakagawa, H. (2022). Modeling Oral-Esophageal Squamous Cell Carcinoma in 3D Organoids. Journal of Visualized Experiments, 2022(190), Artículo e64676. https://doi.org/10.3791/64676